← Evidence map

ArticleSkin health and disease2021

T-cell pseudolymphoma secondary to ixazomib for multiple myeloma.

M Haq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35663138